DDO anticorps (N-Term)
Aperçu rapide pour DDO anticorps (N-Term) (ABIN926707)
Antigène
Voir toutes DDO AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Purification
- Purified
-
Immunogène
- DDO antibody was raised in rabbit using the N terminal of DDO as the immunogen
-
-
-
-
Indications d'application
- Optimal conditions should be determined by the investigator.
-
Commentaires
-
DDO Blocking Peptide, (ABIN5613151), is also available for use as a blocking control in assays to test for specificity of this DDO antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- DDO (D-Aspartate Oxidase (DDO))
-
Autre désignation
- DDO
-
Sujet
- The protein encoded by this gene is a peroxisomal flavoprotein that catalyzes the oxidative deamination of D-aspartate and N-methyl D-aspartate. Flavin adenine dinucleotide or 6-hydroxyflavin adenine dinucleotide can serve as the cofactor in this reaction. Two transcript variants encoding different isoforms have been found for this gene. Synonyms: Polyclonal DDO antibody, Anti-DDO antibody, D-aspartate oxidase antibody, DASOX antibody, DDO-1 antibody, DDO-2 antibody, FLJ45203 antibody.
Antigène
-